DFD-29 on it’s way, now has an NDA

Written by on January 10, 2024 in Minocycline, New Rosacea Treatments, tetracyclines with 0 Comments

Journey Medical’s modified released 40mg minocycline (still code named DFD-29) has published positive Phase 3 Clinical Trial data and is now sitting waiting on a New Drug Application. The company press release touts the combination treatment for both the inflammatory lesions and the redness of rosacea. By comparison, Oracea, the competing product that DFD-29 claims to out-perform, is not indicated for the redness off rosacea, only for the treatment of the papules and pustules of rosacea.

The press release contains the somewhat hopeful claim that “DFD-29 could fundamentally improve the treatment paradigm for patients suffering from both inflammatory lesions and erythema (redness) from rosacea”.

There is a still long way to go before rosacea sufferers get to see whether this new form of a tetracycline will offer a significant benefit over Oracea. It is encouraging, though, that this in-development product has made it to NDA stage.

DFD-29 NDA Press Release

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

SCOTTSDALE, Ariz., Jan. 05, 2024 (GLOBE NEWSWIRE) —  Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that the Company has submitted a New Drug Application (“NDA”) to the FDA seeking approval for DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) for the treatment of inflammatory lesions and erythema of rosacea in adults. DFD-29 is being developed in collaboration with Dr. Reddy’s Laboratories Ltd.

Related Articles

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

Leave your comment here


Discover more from Rosacea Support Group

Subscribe now to keep reading and get access to the full archive.

Continue reading

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.